Adenosine

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
ANDA078076 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Adenosine Injection Is Indicated For The Following. Conversion To Sinus Rhythm Of Paroxysmal Supraventricular Tachycardia (psvt), Including That Associated With Accessory Bypass Tracts (wolff-Parkinson-White Syndrome). When Clinically Advisable, Appropriate Vagal Maneuvers (e.g., Valsalva Maneuver), Should Be Attempted Prior To Adenosine Administration. It Is Important To Be Sure The Adenosine Solution Actually Reaches The Systemic Circulation (see Dosage And Administration ). Adenosine Does Not Convert Atrial Flutter, Atrial Fibrillation, Or Ventricular Tachycardia To Normal Sinus Rhythm. In The Presence Of Atrial Flutter Or Atrial Fibrillation, A Transient Modest Slowing Of Ventricular Response May Occur Immediately Following Adenosine Administration.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Adenosine ADENOSINE ZINC2169830

Comments